The Net Margin of Alnylam Pharmaceuticals Inc (ALNY) is -12.37%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -12.37% |
2023-12-31 | -24.08% |
2022-12-31 | -109.04% |
2021-12-31 | -101.01% |
2020-12-31 | -174.13% |
2019-12-31 | -403.14% |
2018-12-31 | -1016.69% |
2017-12-31 | -546.05% |
2016-12-31 | -868.86% |
2015-12-31 | -705.84% |